153 related articles for article (PubMed ID: 19775824)
1. Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer.
Mayr NA; Wang JZ; Zhang D; Grecula JC; Lo SS; Jaroura D; Montebello J; Zhang H; Li K; Lu L; Huang Z; Fowler JM; Wu DH; Knopp MV; Yuh WT
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):502-8. PubMed ID: 19775824
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of hemoglobin and tumor perfusion on tumor control and survival in cervical cancer.
Mayr NA; Wang JZ; Zhang D; Montebello JF; Grecula JC; Lo SS; Fowler JM; Yuh WT
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1513-21. PubMed ID: 19286329
[TBL] [Abstract][Full Text] [Related]
3. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.
Zahra MA; Tan LT; Priest AN; Graves MJ; Arends M; Crawford RA; Brenton JD; Lomas DJ; Sala E
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):766-73. PubMed ID: 19019563
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance.
Andersen EK; Hole KH; Lund KV; Sundfør K; Kristensen GB; Lyng H; Malinen E
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e485-92. PubMed ID: 22014954
[TBL] [Abstract][Full Text] [Related]
5. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
[TBL] [Abstract][Full Text] [Related]
6. Interstitial fluid pressure as a prognostic factor in cervical cancer following radiation therapy.
Yeo SG; Kim JS; Cho MJ; Kim KH; Kim JS
Clin Cancer Res; 2009 Oct; 15(19):6201-7. PubMed ID: 19773374
[TBL] [Abstract][Full Text] [Related]
7. Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay.
Mayr NA; Yuh WT; Magnotta VA; Ehrhardt JC; Wheeler JA; Sorosky JI; Davis CS; Wen BC; Martin DD; Pelsang RE; Buller RE; Oberley LW; Mellenberg DE; Hussey DH
Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):623-33. PubMed ID: 8948347
[TBL] [Abstract][Full Text] [Related]
8. Effect of concurrent intra-arterial infusion of platinum drugs for patients with stage III or IV uterine cervical cancer treated with radical radiation therapy.
Onishi H; Yamaguchi M; Kuriyama K; Tsukamoto T; Ishigame K; Ichikawa T; Aoki S; Yoshikawa T; Araki T; Nambu A; Araki T; Hashi A; Yasumizu T; Hoshi K; Ito H
Cancer J Sci Am; 2000; 6(1):40-5. PubMed ID: 10696738
[TBL] [Abstract][Full Text] [Related]
9. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors.
Yeh SA; Wan Leung S; Wang CJ; Chen HC
Gynecol Oncol; 1999 Jan; 72(1):10-5. PubMed ID: 9889023
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy for cervical cancer in the elderly.
Ikushima H; Takegawa Y; Osaki K; Furutani S; Yamashita K; Kawanaka T; Kubo A; Kudoh T; Nishitani H
Gynecol Oncol; 2007 Nov; 107(2):339-43. PubMed ID: 17707075
[TBL] [Abstract][Full Text] [Related]
11. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
[TBL] [Abstract][Full Text] [Related]
12. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy.
Hong JH; Tsai CS; Lai CH; Chang TC; Wang CC; Chou HH; Lee SP; Hsueh S
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):249-57. PubMed ID: 15337563
[TBL] [Abstract][Full Text] [Related]
13. Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging.
Mayr NA; Yuh WT; Zheng J; Ehrhardt JC; Magnotta VA; Sorosky JI; Pelsang RE; Oberley LW; Hussey DH
AJR Am J Roentgenol; 1998 Jan; 170(1):177-82. PubMed ID: 9423627
[TBL] [Abstract][Full Text] [Related]
14. DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery.
Haie-Meder C; Chargari C; Rey A; Dumas I; Morice P; Magné N
Radiother Oncol; 2009 Nov; 93(2):316-21. PubMed ID: 19586673
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment proliferation parameters do not add predictive power to clinical factors in cervical cancer treated with definitive radiation therapy.
Tsang RW; Juvet S; Pintilie M; Hill RP; Wong CS; Milosevic M; Chapman W; Levin W; Manchul LA; Fykes AW
Clin Cancer Res; 2003 Oct; 9(12):4387-95. PubMed ID: 14555510
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
Hille A; Weiss E; Hess CF
Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
[TBL] [Abstract][Full Text] [Related]
17. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy followed by radical surgery and radiotherapy vs. pelvic irradiation in patients with cervical cancer FIGO stage IIB - IVA.
Kornovski Y; Gorchev G
J BUON; 2006; 11(3):291-7. PubMed ID: 17309152
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
[TBL] [Abstract][Full Text] [Related]
20. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival.
Hawighorst H; Knapstein PG; Knopp MV; Weikel W; Brix G; Zuna I; Schönberg SO; Essig M; Vaupel P; van Kaick G
Cancer Res; 1998 Aug; 58(16):3598-602. PubMed ID: 9721867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
